Sicong Liu

Nanjing Key Laboratory Of Intelligent Obstetrics And Gynecology Medicine
Nanjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity.

Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity.

Journal: Oncogene

Published: July 06, 2025

VISTA promotes ovarian cancer progression through activation of NF-κB pathway and tumor microenvironment reprogramming.

VISTA promotes ovarian cancer progression through activation of NF-κB pathway and tumor microenvironment reprogramming.

Journal: Journal of ovarian research

Published: June 25, 2025

B4M3 CAR-T cell enhance antitumor activity and non-tumor toxicity in ovarian cancer.

B4M3 CAR-T cell enhance antitumor activity and non-tumor toxicity in ovarian cancer.

Journal: International immunopharmacology

Published: January 31, 2025

Genetic associations between resting-state brain functional networks and cancer risk: A bidirectional Mendelian randomization study.

Genetic associations between resting-state brain functional networks and cancer risk: A bidirectional Mendelian randomization study.

Journal: Chinese medical journal

Published: January 27, 2025

Causal Links Between Brain Functional Networks and Endometriosis: A Large-Scale Genetic-Driven Observational Study.

Causal Links Between Brain Functional Networks and Endometriosis: A Large-Scale Genetic-Driven Observational Study.

Journal: International journal of women's health

Published: December 14, 2024

tiRNA-Gln-CTG is Involved in the Regulation of Trophoblast Cell Function in Pre-eclampsia and Serves as a Potent Biomarker.

tiRNA-Gln-CTG is Involved in the Regulation of Trophoblast Cell Function in Pre-eclampsia and Serves as a Potent Biomarker.

Journal: Frontiers in bioscience (Landmark edition)

Published: August 30, 2024

Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis.

Potential drug targets for ovarian cancer identified through Mendelian randomization and colocalization analysis.

Journal: Journal of ovarian research

Published: August 14, 2024

VISTA: A promising target for overcoming immune evasion in gynecologic cancers.

VISTA: A promising target for overcoming immune evasion in gynecologic cancers.

Journal: International immunopharmacology

Published: April 30, 2024

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.

Cancer-associated fibroblast-secreted FGF7 as an ovarian cancer progression promoter.

Journal: Journal of translational medicine

Published: November 02, 2023

In Situ Nanofiber Formation Blocks AXL and GAS6 Binding to Suppress Ovarian Cancer Development.

In Situ Nanofiber Formation Blocks AXL and GAS6 Binding to Suppress Ovarian Cancer Development.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: September 01, 2023

Association of smoking, alcohol, and coffee consumption with the risk of ovarian cancer and prognosis: a mendelian randomization study.

Association of smoking, alcohol, and coffee consumption with the risk of ovarian cancer and prognosis: a mendelian randomization study.

Journal: BMC cancer

Published: October 14, 2022

Showing 1-11 of 11

Last Updated: 09/26/2026